All the ways to treat depression
Help for depression goes beyond talk therapy and pills. Exercise, diet, light and newer brain treatments all have research behind them. Below is every option in order, and who offers it near you.
Most people with depression get better with treatment, and mixing approaches tends to beat relying on one. Guidelines now list exercise and group programs next to therapy and medication. There are also proven options when depression has not lifted with the first tries.
We sort the options by how strong the research is. Each card tells you what the approach is, what it involves, what studies found and who offers it.
Whole Wellbeing Atlas lists providers. We do not give medical care. Bring this guide to your doctor or therapist and decide together. In a crisis, call or text 988 (the Suicide and Crisis Lifeline). You can also go straight to the closest emergency room.
Written by the Whole Wellbeing Atlas Editorial Team and reviewed on September 29, 2026. You will find every source at the bottom of the page. How we write and check our guides.
Find these options close to home
Type your ZIP code and we will show local providers under each approach.
Best evidence
Clinical guidelines name these first. This is the place to begin.
Talk therapy (CBT, behavioral activation, interpersonal therapy)
Structured therapies that help you get active again, push back on depressive thinking and mend relationships. They are first-line for mild to moderate depression and belong in care at every level.
Antidepressant medication
Advised most of all for moderate to severe depression, often together with therapy. It can take a few tries to find the right medicine and dose.
Good evidence
Solid trials support these. They pair well with first-line care.
Exercise: walking, running, yoga, strength training
A 2024 review of 218 trials found that exercise cuts depression in a meaningful way. Walking or jogging, yoga and strength training helped most, and harder workouts helped more.
Nutrition therapy
In the SMILES trial, adults with major depression who worked with a dietitian on their diet reached remission about four times as often as the comparison group: 32 percent against 8 percent.
Mindfulness-based cognitive therapy (MBCT)
A group program that runs for eight weeks and lowers the odds that depression comes back. It is meant mainly for people who have had several episodes.
Some evidence
The studies are smaller or mixed. Many people like these as extras next to their main care.
Bright light therapy
You sit by a 10,000 lux light box each morning. It has strong support for seasonal depression and has also helped depression that is not seasonal.
Acupuncture
It may lower depression severity compared with no treatment, though the trials are of low quality. Some people find it a useful extra.
Emerging or specialist
Research is still under way, or these are kept for when first treatments fall short.
Transcranial magnetic stimulation (TMS)
Magnetic pulses stimulate the brain circuits that regulate mood, most often in daily sessions for four to six weeks. It is an established choice after two or more antidepressants have not worked.
Esketamine and ketamine
The FDA has approved esketamine nasal spray for treatment-resistant depression. It is given only in certified clinics. IV ketamine is an off-label use. Either one can start to help within days.
Psilocybin-assisted therapy
In a large 2022 trial, one guided dose helped people with treatment-resistant depression. The FDA has not approved it. You can only get it legally through research or a state program.
Check with a doctor first if
- Thinking about suicide or hurting yourself: call or text 988, or get to the closest emergency room.
- Low mood along with spells of very high energy, little need for sleep or racing thoughts: see a psychiatrist. This may be bipolar disorder, which is treated differently.
- Depression that is new and comes with tiredness, weight change or always feeling cold: ask a doctor to test your thyroid and blood counts.
Sources
- Depression in adults, NICE guideline NG222 (2022)
- NICE guideline NG222
- BMJ, 2024. Noetel et al., network meta-analysis, 218 trials
- BMC Medicine, 2017. Jacka et al., SMILES trial
- JAMA Psychiatry, 2016. Kuyken et al., individual patient data meta-analysis
- American Journal of Psychiatry, 2005. Golden et al., meta-analysis
- Cochrane Review, 2018. Smith et al.
- IPG542, NICE interventional procedures guidance
- Esketamine (Spravato) approved by the FDA, 2019
- New England Journal of Medicine, 2022. Goodwin et al.
Do you provide one of these?
Listing is free. Show up under your approach, in your ZIP code, right beside the research.